In 2019, it was reported (25) that YAP is highly expressed in ovarian cancer, and silencing YAP may significantly inhibit the malignant behavior of ovarian cancer cells by regulating the PI3K/Akt/mTOR pathway. Here, AKT1 is linked to ovarian carcinoma.